Skip to main content
SpringerLink
Log in

Aberrant crypt foci and AgNORs as putative biomarkers to evaluate the chemopreventive efficacy of pronyl-lysine in rat colon carcinogenesis

  • PRECLINICAL STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Chemoprevention opens new perspectives in the prevention of cancer and other degenerative diseases. Use of target-organ biological models at the histological and genetic levels can markedly facilitate the identification of potential chemopreventive agents. Our aim was to study the chemopreventive efficacy of pronyl-lysine, a key antioxidant present in bread crust by evaluating, the total number of aberrant crypt foci (ACF), their distributions, dysplastic ACF, colonic tumor incidence and the expression of cell proliferation biomarker such as the argyrophilic nucleolar organizing region-associated proteins (AgNORs) in 1,2-dimethylhydrazine (DMH) induced colon cancer in rats. Male Wistar rats were randomized into seven groups, group 1 were control rats, group 2 received pronyl-lysine (2 mg/kg body weight p.o. everyday), rats in groups 3–7 were administered DMH (20 mg/kg body weight) in the groin for 15 weeks. In addition, group 4 (pre-initiation), 5 (initiation), 6 (post-initiation), and 7 (entire period) received pronyl-lysine (2 mg/kg body weight p.o) everyday. At the end of 34 weeks, pronyl-lysine supplementation showed markedly reduced tumor incidence, ACF development and also lowered number of AgNORs. Overall, these findings confirm that pronyl-lysine has a positive beneficial effect against chemically induced colonic preneoplastic progression in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130

    PubMed  Google Scholar 

  2. Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49:222–228

    PubMed  CAS  Google Scholar 

  3. Sengottuvelan M, Viswanathan P, Nalini N (2006) Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27:1038–1046

    Article  PubMed  CAS  Google Scholar 

  4. Deeptha K, Kamaleeswari M, Sengottuvelan M, Nalini N (2006) Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats. Invest New Drugs 24:479–488

    Article  PubMed  CAS  Google Scholar 

  5. Lindenmeier M, Faist V, Hofmann T (2002) Structural and functional characterization of pronyl-lysine, a novel protein modification in bread crust melanoidins showing in vitro antioxidative and phase I/II enzyme modulating activity. J Agric Food Chem 50:6997–7006

    Article  PubMed  CAS  Google Scholar 

  6. Marko D, Kemeny M, Bernady E, Habermeyer M, Weyand U, Meiers S, Frank O, Hofmann T (2002) Studies on the inhibition of tumor cell growth and microtubule assembly by 3-hydroxy-4-[(E)-(2-furyl) methylidene]methyl-3-cyclopentene-1,2-dione, an intensively coloured Maillard reaction product. Food Chem Toxicol 40:9–18

    Article  PubMed  CAS  Google Scholar 

  7. Somoza V, Wenzel E, Lindenmeier M, Grothe D, Erbersdobler HF, Hofmann T (2005) Influence of feeding malt, bread crust, and a pronylated protein on the activity of chemopreventive enzymes and antioxidative defense parameters in vivo. J Agric Food Chem 53:8176–8182

    Article  PubMed  CAS  Google Scholar 

  8. Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, Lown KS, Watkins PB (1997) Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrixcoated permeable supports in the presence of 1-alpha, 25-dihydroxyvitamin D3. Mol Pharmacol 51:741–754

    PubMed  CAS  Google Scholar 

  9. Wilkinson J, Clapper ML (1997) Detoxication enzymes and chemoprevention. Proc Soc Exp Biol Med 216:192–200

    PubMed  CAS  Google Scholar 

  10. Somoza V, Lindenmeier M, Hofmann T, Frank O, Erbersdobler Hf, Baynes Jw, Thorpe Sr, Heidland A, Zill H, Bek S, Huber J, Weigle T, Scheidler S, Busch Ae, Sebekova K (2005) Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats. Ann NY Acad Sci 1043:492–500

    Article  PubMed  CAS  Google Scholar 

  11. McLellan EA, Medline A, Bird RP (1991) Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res 51:5270–5274

    PubMed  CAS  Google Scholar 

  12. Yamada Y, Mori H (2003) Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Carcinogenesis 24:1015–1019

    Article  PubMed  CAS  Google Scholar 

  13. Bird RP (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93:55–71

    Article  PubMed  CAS  Google Scholar 

  14. Hirose Y, Kuno T, Yamada Y, Sakata K, Katayama M, Yoshida K, Qiao Z, Hata K, Yoshimi N, Mori H (2003) Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 24:107–111

    Article  PubMed  CAS  Google Scholar 

  15. Wargovich MJ, Chen CD, Jimenez A, Steele VE, Velasco M, Stephens LC, Price R, Gray K, Kelloff GJ (1996) Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5:355–360

    PubMed  CAS  Google Scholar 

  16. Thorup I (1997) Histomorphological and immunochemical characterization of colonic aberrant crypt foci in rats: relation to growth factor expression. Carcinogenesis 18:465–472

    Article  PubMed  CAS  Google Scholar 

  17. Yamada Y, Mori H (2003) Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Carcinogenesis 24:1015–1019

    Article  PubMed  CAS  Google Scholar 

  18. Ruschoff J, Plate K, Bittinger A, Thomas C (1989) Nucleolar organizer regions (NORs). Basic concepts and practical application in tumor pathology. Pathol Res Pract 185:878–885

    PubMed  CAS  Google Scholar 

  19. Contractor H, Ruschoff J, Hanisch T, Ulshofer B, Neumann K, Schultze-Seemann W, Thomas C (1991) Silver-stained structures in prostatic carcinoma: evaluation of diagnostic and prognostic relevance by automated image analysis. Urol Int 46:9–14

    Article  PubMed  CAS  Google Scholar 

  20. Risio M, Rossini FP (1993) Cell proliferation in colorectal adenomas containing invasive carcinoma. Anticancer Res 13:43–47

    PubMed  CAS  Google Scholar 

  21. Ruschoff J, Zimmermann R, Ulshofer B, Thomas C (1992) Silver-stained nucleolar organizer proteins in urothelial bladder lesions. A morphometric study. Pathol Res Pract 188:593–598

    PubMed  CAS  Google Scholar 

  22. Lindenmeier M, Hofmann T (2004) Influence of baking conditions and precursor supplementation on the amounts of the antioxidant pronyl-L-lysine in bakery products. J Agric Food Chem 52:350–354

    Article  PubMed  CAS  Google Scholar 

  23. Ochiai M, Watanabe M, Nakanishi M, Taguchi A, Sugimura T, Nakagama H (2005) Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats. Cancer Lett 220:67–74

    Article  PubMed  CAS  Google Scholar 

  24. Nyska A, Zusman I, Klein T, Sheila N, Weis O, Madar Z, Klein B (1995) Assessment of the nucleolar organizer regions by automated image analysis in benign and malignant colonic tumours and adjacent tissues in rats. J Comp Pathol 113:45–50

    Article  PubMed  CAS  Google Scholar 

  25. Tanaka T, Makita H, Kawamori T, Kawabata K, Mori H, Murakami A, Satoh K, Hara A, Ohigashi H, Koshimizu K (1997) A xanthine oxidase inhibitor 1′-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18:1113–1118

    Article  PubMed  CAS  Google Scholar 

  26. Kanna PS, Mahendrakumar CB, Chakraborty T, Hemalatha P, Banerjee P, Chatterjee M (2003) Effect of vanadium on colonic aberrant crypt foci induced in rats by 1,2 dimethyl hydrazine. World J Gastroenterol 9:1020–1027

    PubMed  CAS  Google Scholar 

  27. Agner AR, Bazo AP, Ribeiro LR, Salvadori DM (2005) DNA damage and aberrant crypt foci as putative biomarkers to evaluate the chemopreventive effect of annatto (Bixa orellana L.) in rat colon carcinogenesis. Mutat Res 582:146–154

    PubMed  CAS  Google Scholar 

  28. Lipkin M (1988) Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 48:235–245

    PubMed  CAS  Google Scholar 

  29. Bird RP, Good CK (2000) The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112–113:395–402

    Article  PubMed  Google Scholar 

  30. Kawamori T, Tanaka T, Hara A, Yamahara J, Mori H (1995) Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res 55:1277–1282

    PubMed  CAS  Google Scholar 

  31. Waitzberg DL, Goncalves EL, Faintuch J, Bevilacqua LR, Rocha CL, Cologni AM (1989) Effect of diets with different protein levels on the growth of Walker 256 carcinosarcoma in rats. Braz J Med Biol Res 22:447–455

    PubMed  CAS  Google Scholar 

  32. Poulsen M, Molck AM, Thorup I, Breinholt V, Meyer O (2001) The influence of simple sugars and starch given during pre- or post-initiation on aberrant crypt foci in rat colon. Cancer Lett 167:135–143

    Article  PubMed  CAS  Google Scholar 

  33. Yamaguchi A, Tsukioka Y, Kurosaka Y, Nishimura G, Kanno M, Yonemura Y, Mivazaki I (1993) Prognostic value of nucleolar organizer regions in endoscopically biopsied tissues of colorectal cancers. Oncology 50:121–126

    Article  PubMed  CAS  Google Scholar 

  34. Wong WM, Wright NA (1999) Cell proliferation in gastrointestinal mucosa. J Clin Pathol 52:321–333

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This work was supported by the Department of Biotechnology (DBT), Ministry of Science & Technology, New Delhi in the form of a Junior Research Fellowship to J. Panneer Selvam and is gratefully acknowledged.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, 608 002, Tamilnadu, India

    Jayabal Panneer Selvam, Selvaraj Aranganathan & Namasivayam Nalini

Authors
  1. Jayabal Panneer Selvam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Selvaraj Aranganathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Namasivayam Nalini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Namasivayam Nalini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panneer Selvam, J., Aranganathan, S. & Nalini, N. Aberrant crypt foci and AgNORs as putative biomarkers to evaluate the chemopreventive efficacy of pronyl-lysine in rat colon carcinogenesis. Invest New Drugs 26, 531–540 (2008). https://doi.org/10.1007/s10637-008-9122-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-008-9122-7

Keywords

Search

Navigation